advanc
plant
biotechnolog
last
two
decad
facilit
product
recombin
protein
plant
includ
subunit
vaccin
antigen
sever
good
review
articl
rybicki
streatfield
thanavala
et
al
yusibov
rabindran
summar
much
work
focus
attent
util
plant
subunit
vaccin
express
twenti
year
sinc
semin
work
demonstr
potenti
plantderiv
vaccin
curtiss
cardineau
mason
et
al
larg
bodi
literatur
demonstr
express
antigen
mani
plant
includ
edibl
plant
like
corn
potato
tomato
well
tobacco
rel
yet
commerci
develop
plantderiv
vaccin
product
slow
varieti
reason
discuss
previous
rybicki
one
biggest
obstacl
reluct
pharmaceut
industri
invest
new
technolog
exist
seem
adequ
howev
steadi
accumul
promis
data
shown
plantbas
express
great
potenti
especi
hurdl
overcom
origin
ofttout
goal
plantderiv
vaccin
provid
cheap
conveni
deliv
oral
recombin
subunit
vaccin
underdevelop
countri
poor
econom
condit
limit
applic
modern
medic
scienc
hypothesi
ingest
edibl
plant
materi
either
raw
minim
process
could
induc
protect
immun
respons
via
activ
immun
effector
gutassoci
lymphoid
tissu
galt
streatfield
thanavala
et
al
oral
deliveri
bacteri
antigen
gener
protect
immun
enter
pathogen
howev
scarc
evid
protect
respiratori
urogenit
tract
infecti
diseas
achiev
use
oral
vaccin
deliveri
rout
digest
acid
proteas
degrad
protein
nutrient
absorpt
substanti
problem
oral
vaccin
develop
antigen
must
rel
resist
gut
proteas
typic
larg
antigen
dose
administ
encapsul
might
better
protect
immunogen
deliveri
galt
streatfield
howev
littl
work
area
done
plantderiv
antigen
anoth
problem
edibl
vaccin
accumul
antigen
transgen
plant
tissu
usual
rather
low
total
solubl
protein
tsp
creat
requir
process
plant
materi
concentr
antigen
moreov
inher
planttopl
variabl
antigen
content
requir
process
plant
materi
produc
wellcharacter
batch
antigen
administ
control
dosag
thu
plantderiv
oral
vaccin
immunogen
requir
substanti
purif
concentr
probabl
deliveri
capsul
protect
proteolyt
degrad
small
intestin
recent
plantbas
recombin
protein
product
revolution
transient
express
antigen
plant
use
viral
vector
gleba
et
al
yusibov
et
al
plant
host
usual
tobacco
rel
nicotiana
benthamiana
goodin
et
al
remark
permiss
mani
plant
virus
express
level
obtain
viral
vector
n
benthamiana
leav
variabl
depend
protein
gener
tenfold
greater
stabl
transform
nuclear
genom
frequent
rang
mgkg
leaf
mass
thu
prospect
plantbas
express
purif
vaccin
antigen
especi
viruslik
particl
vlp
huang
et
al
mucos
deliveri
substanti
brighter
obtain
use
stabli
integr
transgen
moreov
high
yield
recombin
antigen
obtain
use
viral
vector
may
facilit
intranas
deliveri
requir
smaller
volum
henc
concentr
vaccin
solut
oral
deliveri
rout
ideal
mucos
vaccin
would
induc
antibodi
cellmedi
protect
relev
mucos
site
also
throughout
bodi
conveni
mean
achiev
mucos
immun
global
health
program
oral
deliveri
oral
vaccin
elimin
possibl
transmiss
infecti
diseas
contamin
needl
well
elimin
pain
associ
inject
need
train
personnel
deliv
vaccin
holmgren
czerkinski
lavel
howev
nasal
vaccin
hamper
physic
chemic
barrier
gut
nasal
vaccin
demonstr
particular
potenti
regard
induct
broadli
dissemin
immun
neutra
kozlowski
staat
et
al
human
monkey
mice
nasal
immun
induc
antigenspecif
mucos
iga
respons
salivari
gland
upper
lower
respiratori
tract
small
larg
intestin
notabl
male
femal
reproduct
tract
harandi
et
al
imaoka
et
al
kozlowski
et
al
rudin
et
al
staat
et
al
addit
nasal
rout
immun
induc
cytotox
lymphocyt
ctl
distant
mucos
tissu
includ
femal
reproduct
tract
gallichan
rosenth
human
mice
nasal
immun
produc
greater
system
antibodi
respons
mucos
immun
rout
kozlowski
et
al
staat
et
al
kunkel
butcher
provid
evid
human
vaccin
recipi
mucos
immun
prime
immun
system
mucos
system
respons
induc
express
mucos
system
home
receptor
respond
lymphocyt
thu
deliveri
subunit
antigen
vlp
via
nasal
rout
excel
prospect
vaccin
strategi
read
vlp
vaccin
reader
direct
volum
strategi
use
recombin
protein
express
plant
conceptu
similar
use
mammalian
yeast
eukaryot
host
rybicki
thanavala
et
al
yusibov
rabindran
includ
stabli
integr
transgen
nuclear
chloroplast
genom
transient
express
use
vector
either
nonrepl
util
plant
viru
replic
element
amplifi
mrna
target
gene
nuclear
gene
behav
mendelian
fashion
util
typic
eukaryot
pathway
protein
translat
process
subcellular
local
organ
develop
stagespecif
promot
util
foreign
protein
direct
accumul
seed
nochi
et
al
streatfield
et
al
wu
et
al
express
antigen
seed
particular
advantag
regard
protein
stabil
due
dri
storag
tissu
seed
develop
thu
seed
store
ambient
temperatur
month
year
littl
loss
protein
activ
although
sitespecif
recombin
plant
nuclear
genom
studi
intens
hanin
paszkowski
current
routin
usual
rather
ineffici
case
recombin
construct
deliv
dna
use
agrobacterium
tumefacien
plant
pathogen
abil
transfer
gene
plant
cell
nucleu
gelvin
foreign
dna
may
integr
stabli
host
nuclear
chromosom
dna
nonhomolog
recombin
random
site
although
work
suggest
transcript
activ
site
may
preferenti
target
transfer
dna
may
also
resid
nucleu
without
integr
sever
day
thu
act
templat
transcript
effect
transient
express
unless
foreign
dna
construct
viral
replicon
remain
lowcopi
number
use
evalu
express
foreign
antigen
huang
mason
agrobacteriummedi
dna
transfer
also
use
deliv
viral
replicon
dna
virus
geminivirus
use
develop
gene
amplif
system
huang
et
al
genom
rna
virus
tobacco
mosaic
viru
tmv
construct
cdna
fuse
plant
promot
transcrib
nucleu
produc
viral
rna
move
cytoplasm
establish
replic
gleba
et
al
method
call
magnifect
develop
allow
wholepl
inocul
n
benthamiana
vacuum
infiltr
agrobacterium
line
contain
recombin
tmv
replicon
lack
coat
protein
result
foreign
gene
express
leav
gleba
et
al
recombin
viral
genom
also
deliv
directli
rna
vitro
transcript
plasmid
simpli
abrad
leaf
surfac
appli
solut
rna
gleba
et
al
yusibov
et
al
case
replicon
need
contain
viral
element
mediat
longdist
transport
plant
vasculatur
express
restrict
site
inocul
chloroplast
transform
routin
laboratori
yield
highexpress
level
antigen
due
high
gene
copi
number
mani
chloroplast
per
cell
genom
molecul
per
chloroplast
arlen
et
al
singh
et
al
dna
construct
deliv
micro
projectil
bombard
gene
gun
sitespecif
recombin
allow
target
gene
insert
one
great
advantag
chloroplast
transgen
usual
subject
gene
silenc
mediat
rna
interfer
common
problem
nuclear
transgen
anoth
advantag
chloroplast
genom
exclus
matern
inherit
make
gene
contain
much
easier
pollen
grain
devoid
plastid
howev
chloroplast
genet
system
prokaryot
one
thu
protein
process
event
notabl
glycosyl
occur
norovirus
nonenvelop
positivesens
rna
member
calicivirida
enter
pathogen
caus
gastroenter
capsid
protein
norwalk
viru
nvcp
express
insect
cell
jiang
et
al
plant
mason
et
al
selfassembl
vlp
rnv
oral
immunogen
clinic
studi
evalu
antibodi
respons
ingest
dose
g
raw
potato
tuber
express
rnv
tacket
et
al
although
subject
ingest
rnv
express
potato
develop
measur
increas
circul
antibodysecret
cell
overal
respons
rather
weak
variabl
rnv
content
tuber
per
dose
rel
poor
vlp
assembl
potato
effect
rnv
dose
per
dose
like
limit
factor
howev
detriment
effect
potato
vehicl
perhap
due
poor
releas
vlp
gut
lumen
discount
clinic
trial
use
oral
deliv
purifi
insect
cellderiv
rnv
irnv
produc
stronger
antibodi
respons
per
dose
obtain
potato
tacket
et
al
suggest
purifi
rnv
potent
oral
immunogen
later
rnv
express
higher
level
transgen
tomato
fruit
use
plant
codonoptim
nvcp
gene
zhang
et
al
oral
immunogen
mice
excel
dose
g
tomato
fruit
contain
nvcp
rnv
induc
antirnv
serum
igg
fecal
iga
mice
g
dose
gener
system
mucos
antibodi
mice
also
shown
airdri
tomato
fruit
least
activ
mice
tomato
indic
sophist
dri
technolog
requir
rnv
tomato
interestingli
rnv
deliv
potato
tuber
less
oral
immunogen
mice
due
oxid
phenol
compound
polyphenol
oxidas
potato
zhang
et
al
tomato
much
better
respect
lowphenol
content
well
high
level
ascorb
acid
act
antioxid
thu
dri
rnv
tomato
fruit
would
worthi
studi
human
recent
year
group
experi
viral
vector
transient
express
rnv
plant
potenti
highlevel
express
rapid
protein
product
gleba
et
al
marillonnet
et
al
use
magnifect
system
express
nvcp
tobacco
rel
n
benthamiana
level
mgkg
leaf
tissu
santi
et
al
develop
vlp
purif
process
requir
ultracentrifug
instead
util
ph
precipit
major
leaf
protein
follow
filtrat
kda
membran
remov
unassembl
nvcp
subunit
absenc
adjuv
tobaccoderiv
rnv
trnv
oral
immunogen
mice
dose
gener
system
mucos
antirnv
antibodi
santi
et
al
inclus
cholera
toxin
adjuv
trnv
substanti
increas
antirnv
respons
velasquez
et
al
studi
mice
found
nasal
codeliveri
trnv
tolllik
receptor
tlr
agonist
produc
robust
system
mucos
antigenspecif
antibodi
respons
undertook
experi
evalu
potenti
vlp
induc
distal
mucos
iga
respons
without
adjuv
unpublish
studi
examin
agonist
cpgcontain
oligodeoxynucleotid
cpgodn
adjuv
known
trigger
immunostimulatori
cascad
culmin
matur
differenti
prolifer
multipl
cell
type
includ
b
cell
cpgodn
use
previous
mice
nasal
rout
abe
et
al
balmelli
et
al
mccluski
et
al
nasal
immun
consciou
femal
balbc
mice
purifi
trnv
alon
trnv
type
b
cpgodn
nasal
immun
consciou
mice
vlp
shown
target
antigen
nasopharyngealassoci
lymphoid
tissu
nalt
deeper
respiratori
tract
tissu
balt
wherea
nasal
immun
sedat
mice
analog
intratrach
administr
balmelli
et
al
also
immun
mice
oral
trnv
alon
rnvspecif
antibodi
induc
serum
analyz
determin
immun
produc
mix
immun
respons
overal
rnvspecif
serum
igg
level
higher
nasal
versu
oral
immun
mice
greatest
level
achiev
nasal
codeliveri
cpgodn
rnv
fig
within
nasal
group
antirnv
serum
significantli
increas
cpgodn
immun
group
rel
control
suggest
cpgodn
drive
mix
respons
respect
product
antirnv
antibodi
immun
anim
igg
level
increas
day
follow
singl
immun
continu
rise
follow
booster
immun
day
intranas
oral
oral
antibodi
level
began
plateau
day
fig
oral
deliv
trnv
immunogen
howev
nasal
immun
trnv
produc
robust
immun
respons
fecal
iga
produc
cpgodn
immun
group
fig
addit
level
rnvspecif
iga
igg
vagin
lavag
significantli
elev
p
nasal
group
given
rnv
cpgodn
fig
f
character
distal
induct
antigenspecif
iga
evalu
iga
product
addit
mucos
site
includ
salivari
sampl
gastrointestin
lavag
nasal
wash
bronchoalveolar
lavag
distal
mucos
site
iga
product
significantli
increas
rel
control
rnvcpgodnimmun
mice
fig
result
demonstr
trnv
codeliv
tlr
agonist
nasal
rout
induc
robust
antigenspecif
iga
product
distal
mucos
site
would
import
mucos
protect
enter
organ
also
respiratori
pathogen
overal
data
demonstr
immun
trnv
nasal
rout
effect
oral
rout
induc
robust
rnvspecif
system
igg
mucos
iga
antibodi
respons
upper
lower
respiratori
nasal
bronchoalveolar
gastrointestin
salivari
intestin
fecal
femal
reproduct
vagin
tract
plan
phase
clinic
trial
evalu
system
mucos
antibodi
respons
trnv
nasal
deliveri
select
adjuv
chronic
infect
hepat
b
viru
hbv
result
liver
cancer
account
one
million
death
per
year
among
approxim
million
chronic
carrier
worldwid
hbv
transmit
mainli
blood
sexual
contact
vertic
transmiss
occur
frequent
mother
give
birth
regard
mucos
hbv
vaccin
may
improv
current
intramuscular
hepat
b
surfac
antigen
hbsag
vaccin
made
recombin
yeast
mcaleer
et
al
moreov
oral
deliv
plantderiv
vaccin
could
improv
patient
complianc
multipl
dose
due
conveni
would
obviat
need
needl
howev
must
take
care
avoid
interfer
current
effort
expand
hbv
vaccin
develop
world
move
forward
plantderiv
vaccin
distinct
advantag
demonstr
percept
among
plant
vaccinologist
plantderiv
hbv
vaccin
import
appar
larg
bodi
work
demonstr
express
hbsag
varieti
plant
includ
potato
lettuc
tomato
tomatillo
corn
banana
streatfield
first
public
plantbas
vaccin
antigen
express
hbsag
transgen
tobacco
mason
et
al
optim
hbsag
express
transgen
potato
tuber
richter
et
al
oral
immunogen
mice
albeit
depend
upon
inclus
ct
kong
et
al
encourag
human
trial
due
fda
concern
immunolog
subject
might
experi
antigen
toler
ingest
hbsag
clinic
studi
use
hbsag
seroposit
volunt
previous
vaccin
yeast
recombin
hbsag
thanavala
et
al
titer
antihbsag
serum
increas
volunt
consum
dose
transgen
potato
respect
dose
contain
roughli
hbsag
find
suggest
oral
boost
plantderiv
hbsag
could
incorpor
viabl
compon
immun
program
oral
deliveri
hbsag
activ
system
memori
cell
gener
intramuscular
immun
howev
possibl
prime
immun
hbsag
potato
ingest
exclud
earlier
studi
shown
presum
human
subject
ingest
transgen
lettuc
express
low
level
hbsag
underw
seroconvers
kapusta
et
al
interest
note
neither
clinic
trial
employ
adjuv
suggest
oral
deliveri
substanti
optim
work
fear
oral
toler
one
must
taken
serious
howev
littl
work
address
issu
plantderiv
vaccin
one
recent
paper
examin
regulatori
cell
treg
human
mice
oral
immun
transgen
hbsag
tobacco
kostrzak
et
al
regulatori
cell
mediat
immunolog
unrespons
selfantigen
implic
oral
toler
sakaguchi
et
al
human
mice
immun
gavag
differ
amount
powder
tobacco
leav
treg
measur
spleen
peripher
lymph
node
kostrzak
et
al
serum
igg
fecal
iga
invers
correl
antigen
dose
frequenc
treg
posit
correl
tobacco
dose
lead
author
conclud
oral
toler
occur
higher
dose
data
strongli
conclus
due
rel
poor
antibodi
respons
rate
among
group
suggest
absenc
adjuv
oral
plant
vaccin
may
induc
toler
highervaccin
dosag
necessarili
better
nonetheless
much
work
need
differ
antigen
plant
vehicl
dosag
order
make
firm
conclus
regard
potenti
plantderiv
antigen
induc
oral
toler
rabi
zoonot
diseas
invari
fatal
develop
clinic
symptom
nagarajan
et
al
human
death
rabi
occur
develop
countri
new
technolog
like
plantderiv
recombin
antibodi
vaccin
could
make
signific
impact
yusibov
colleagu
yusibov
et
al
shown
oral
deliveri
rabi
viru
epitop
express
spinach
immunogen
human
chimer
peptid
contain
determin
rabi
viru
glycoprotein
g
protein
nucleoprotein
n
protein
fuse
nterminu
alfalfa
mosaic
viru
coat
protein
express
viral
vector
tobacco
spinach
viru
particl
express
mg
per
g
leaf
tissu
recov
purifi
form
mice
intraperiton
dose
recombin
viru
particl
rabi
peptid
gener
neutral
antibodi
protect
lethal
rabi
viru
challeng
thu
human
studi
perform
use
volunt
previous
receiv
convent
rabi
vaccin
hbv
potato
vaccin
concern
potenti
oral
toler
five
subject
fed
g
raw
recombin
spinach
leav
mg
recombin
viru
chimer
rabi
peptid
per
dose
total
time
biweekli
interv
anoth
five
subject
ingest
control
vectoronli
spinach
three
antigentr
volunt
none
individu
control
group
show
signific
boost
antirabi
viru
antibodi
serum
base
result
subject
test
nine
volunt
consum
dose
raw
rabiesrecombin
spinach
leav
g
per
dose
fed
control
spinach
subject
receiv
singl
dose
commerci
rabi
vaccin
day
last
oral
dose
six
subject
ate
rabi
antigencontain
spinach
show
signific
increas
serum
igg
iga
specif
rabi
viru
yusibov
et
al
result
similar
obtain
hbsagexpress
potato
thanavala
et
al
although
greater
respons
rate
would
desir
studi
demonstr
potenti
success
oral
deliveri
plantderiv
vaccin
human
littl
work
rabi
vaccin
report
one
studi
lozarubio
et
al
rabi
viru
g
protein
express
transgen
maiz
seed
tsp
mice
fed
singl
dose
transgen
seed
contain
g
protein
challeng
day
later
lethal
dose
rabi
viru
vaccin
induc
virusneutr
antibodi
impress
protect
mice
challeng
result
suggest
maiz
seed
may
ideal
vehicl
express
deliveri
rabi
g
protein
measl
viru
mv
caus
substanti
morbid
mortal
worldwid
develop
countri
carri
heaviest
burden
due
instabl
attenu
viru
vaccin
requir
inocul
needl
webster
et
al
moreov
evid
indic
vaccin
individu
gener
less
robust
longlast
antibodi
titer
individu
recov
natur
mv
infect
muller
et
al
thu
boost
conveni
mucos
deliv
mv
vaccin
would
great
boon
health
especi
resourcepoor
countri
two
group
research
approach
problem
use
plantderiv
vaccin
webster
colleagu
express
solubl
form
mv
hemagglutinin
mvh
surfac
protein
stabl
transgen
tobacco
lettuc
webster
et
al
mvh
stabl
lettuc
leaf
store
room
temperatur
month
show
loss
month
webster
et
al
moreov
dri
mvh
oral
immunogen
mice
resuspens
deliveri
gavag
crude
saponin
adjuv
sinc
refer
standard
avail
amount
mvh
antigen
lettuc
could
accur
determin
best
result
obtain
mice
system
prime
mvh
dna
vaccin
oral
boost
five
time
lettuc
express
mvh
mean
titer
mvspecif
serum
igg
boost
tenfold
oral
dose
control
lettuc
effect
virusneutr
titer
roughli
higher
mvh
lettuc
boost
mice
control
lettuc
mice
data
indic
potenti
oral
boost
plantderiv
mvh
human
intramuscularli
vaccin
experi
wane
antimv
antibodi
titer
anoth
group
use
mv
polyepitop
strategi
express
four
copi
hemagglutinin
protect
b
cell
epitop
fuse
four
repeat
human
promiscu
cell
epitop
tetanu
toxoid
transgen
carrot
bouch
et
al
although
vaccin
deliv
intraperiton
rout
mucos
antigen
immunogen
gener
serum
antibodi
neutral
ten
differ
mv
strain
approach
might
develop
oral
nasal
deliveri
appropri
mucos
adjuv
order
produc
vaccin
conveni
popul
develop
countri
plantderiv
mv
vaccin
test
human
yet
data
show
promis
indic
oral
boost
could
provid
substanti
benefit
first
plantderiv
vaccin
immunogen
test
human
b
subunit
protein
enterotoxigen
escherichia
coli
toxin
lt
express
transgen
potato
mason
et
al
tacket
et
al
nontox
ltb
protein
mediat
bind
lt
holotoxin
epitheli
cell
trigger
intracellular
deliveri
toxic
subunit
rational
mucos
vaccin
rational
presum
oral
deliveri
ltb
induc
local
secret
antiltb
antibodi
gut
prevent
bind
holotoxin
enterocyt
data
mous
studi
support
hypothesi
mice
ingest
ltbcontain
potato
tuber
partial
protect
lt
challeng
indic
reduc
fluid
secret
small
intestin
mason
et
al
clinic
trial
show
ingest
ltb
potato
stimul
antilt
serum
igg
subject
serum
iga
six
subject
fecal
iga
subject
show
antibodi
could
neutral
lt
tacket
et
al
anoth
clinic
trial
use
transgen
maiz
germ
embryo
seed
express
ltb
yield
similar
result
tacket
et
al
fact
ltb
one
oral
immunogen
protein
known
diminish
impact
find
provid
clear
evid
ingest
crude
plant
materi
absenc
adjuv
could
potenti
stimul
protect
antibodi
respons
enter
pathogen
human
recent
transgen
rice
seed
express
structur
function
similar
b
subunit
cholera
toxin
develop
nochi
et
al
cholera
toxin
b
subunit
ctb
express
rice
seed
use
seed
storag
protein
promot
per
seed
tsp
local
protein
storag
bodi
allow
high
stabil
immunogen
year
room
temperatur
resist
pepsin
treatment
thu
rice
corn
appear
good
vehicl
deliveri
antigen
gut
plantderiv
vaccin
enterohemorrhag
e
coli
also
creat
express
part
bacteri
adhesin
intimin
cultur
transgen
tobacco
cell
judg
et
al
ctermin
domain
intimin
mediat
bind
transloc
intimin
receptor
well
surfac
molecul
bacteri
colon
gut
oral
immun
mice
ingest
express
tobacco
cell
intraperiton
prime
plantderiv
stimul
specif
fecal
iga
mice
reduc
bacteri
shed
challeng
judg
et
al
howev
low
express
transgen
tobacco
cell
limit
amount
antigen
could
produc
use
viral
vector
transient
express
research
team
substanti
enhanc
express
leav
n
benthamiana
e
topal
h
mason
manuscript
prepar
test
appropri
host
cattl
need
assess
efficaci
intimin
express
plantbas
vaccin
prevent
infect
e
coli
footandmouth
diseas
viru
fmdv
import
veterinari
pathogen
highli
infecti
anim
econom
devast
effect
meat
milk
product
fmdv
capsid
protein
contain
virusneutr
determin
wigdorovitz
et
al
sever
studi
shown
express
variou
plant
host
yusibov
rabindran
transgen
alfalfa
leav
immunogen
mice
intraperiton
oral
deliveri
wigdorovitz
et
al
oral
deliveri
mice
fed
g
fresh
leav
three
time
per
week
week
ten
day
later
serum
obtain
mice
two
separ
experi
develop
serum
antibodi
fmdv
particl
titer
rang
moreov
mice
protect
intraperiton
challeng
fmdv
measur
absenc
viremia
h
later
none
control
mice
protect
differ
strategi
fuse
epitop
amino
acid
gu
stabl
enzym
readili
measur
use
fluorometr
assay
du
santo
et
al
express
transgen
alfalfa
plant
rang
tsp
crude
extract
inject
intraperiton
rout
elicit
complet
protect
immun
respons
mice
anoth
fusion
protein
studi
use
amino
acid
replac
ntermin
residu
bamboo
mosaic
viru
coat
protein
recombin
viru
use
infect
leav
chenopdium
quinoa
spinach
rel
yang
et
al
infect
leav
produc
chimer
virion
express
epitop
coat
protein
although
yield
recombin
protein
quantifi
data
suggest
accumul
tsp
yang
et
al
intramuscular
immun
pig
mg
virion
result
induct
antifmdv
neutral
antibodi
cell
complet
protect
fmdv
challeng
high
antigen
dose
use
studi
indic
robust
express
viral
coat
protein
fusion
view
promis
result
obtain
oral
deliveri
plantderiv
wigdorovitz
et
al
perhap
surpris
later
fusion
protein
strategi
yield
improv
express
test
oral
rout
investig
need
order
evalu
oral
deliveri
adjuv
anim
speci
econom
relev
transmiss
gastroenter
viru
tgev
coronaviru
significantli
affect
swine
product
hammond
nemchinov
diseas
highli
infecti
sever
diarrhea
vomit
produc
high
mortal
young
piglet
envelop
spike
protein
target
neutral
antibodi
thu
express
plant
system
oral
deliveri
howard
lamphear
et
al
transgen
corn
seed
express
tgev
protein
fed
piglet
stimul
antibodi
product
partial
protect
anim
viral
challeng
howard
truncat
solubl
protein
product
target
cell
wall
instead
protein
bodi
allow
accumul
antigen
mgkg
seed
dose
mg
protein
singl
feed
studi
examin
potenti
immun
gilt
young
sow
stimul
anti
antibodi
secret
milk
protect
suckl
piglet
lamphear
et
al
oral
dose
ingest
tgev
corn
gilt
day
farrow
day
receiv
modifi
live
tgev
vaccin
oral
day
stimul
significantli
higher
tgevneutr
activ
serum
colostrum
day
milk
day
compar
placebo
group
antibodi
isotyp
determin
author
suggest
milk
antibodi
later
day
two
mostli
iga
lamphear
et
al
protect
efficaci
examin
neutral
titer
milk
suggest
suckl
piglet
would
protect
howev
milk
titer
drop
precipit
day
suggest
continu
boost
would
necessari
maintain
protect
interest
chimer
antibodi
tgev
express
plant
test
abil
protect
piglet
oral
deliveri
monger
et
al
investig
fuse
antitgev
singlechain
antibodi
scfv
domain
ige
mediat
dimer
protein
express
cowpea
leav
use
cowpea
mosaic
viru
vector
achiev
accumul
tsp
plantderiv
antibodi
dub
immun
protein
show
similar
tgevneutr
activ
parent
antibodi
express
mammalian
cell
moreov
oral
gavag
piglet
reduc
viral
titer
lung
gut
piglet
challeng
tgev
though
less
effect
antibodi
studi
illustr
potenti
plantderiv
antibodi
provid
mucos
protect
enter
viral
diseas
deserv
attent
applic
veterinari
human
medicin
infecti
bursal
diseas
viru
ibdv
highli
contagi
deadli
young
chicken
thu
major
econom
impact
poultri
industri
ibdv
member
birnavirida
two
rna
genom
segment
wu
et
al
viral
capsid
protein
immunodomin
antigen
gener
antivir
neutral
antibodi
current
use
vaccin
either
attenu
kill
virus
suffer
problem
regard
potenti
live
viru
vaccin
recombin
gener
variant
poor
efficaci
case
wholekil
vaccin
one
compel
plantderiv
vaccin
success
date
recombin
deliv
oral
express
leav
arabidopsi
thaliana
level
tsp
wu
et
al
among
highest
obtain
recombin
subunit
vaccin
stabli
transform
plant
leav
transgen
plant
dri
powder
resuspend
water
oral
deliveri
wu
et
al
oneweek
old
bird
receiv
five
oral
dose
day
interv
per
dose
live
intermedi
vaccin
prime
follow
boost
oral
although
prime
bird
develop
serum
antibodi
earlier
titer
similar
three
group
week
furthermor
group
exhibit
similar
protect
challeng
virul
ibdv
wu
et
al
later
express
stabl
transgen
rice
seed
tsp
per
seed
wu
et
al
two
week
old
chicken
fed
weekli
dose
g
rice
seed
receiv
live
attenu
nasal
viru
vaccin
serum
antibodi
increas
week
follow
immun
g
oral
group
attain
level
similar
nasal
vaccin
group
among
differ
oral
group
antibodi
level
posit
correl
dosag
interestingli
g
oral
group
better
protect
virul
ibdv
challeng
vaccin
group
vs
respect
although
bursal
lesion
score
use
calcul
efficaci
could
consid
somewhat
subject
efficaci
correl
oral
antigen
dose
wu
et
al
estim
g
rice
seed
contain
roughli
mg
dose
protein
rather
high
regard
seed
distinct
advantag
leav
enabl
high
dose
well
excel
protein
stabil
longterm
storag
actinobacillu
pleuropneumonia
agent
porcin
pleuropneumonia
import
swine
diseas
although
pathogen
mechan
fulli
understood
apx
toxin
associ
bacteri
virul
shin
et
al
apx
ii
iii
toxin
mediat
virul
insert
host
cell
membran
creat
pore
thu
may
good
target
immun
intervent
diseas
one
group
demonstr
protect
potenti
apxia
apxiia
protein
vaccin
antigen
oral
deliveri
mice
lee
et
al
shin
et
al
first
studi
use
yeast
saccharomyc
cerevisia
express
apxiia
oral
deliveri
mice
show
apxiiaspecif
iga
product
lung
intestin
well
partial
dosedepend
protect
challeng
pleuropneumonia
second
studi
stabl
transgen
tobacco
use
express
apxiia
rel
low
level
tsp
lee
et
al
mice
gavag
weekli
dose
dri
tobacco
leaf
mg
mg
dri
mass
estim
contain
ng
apxiia
suspend
pb
evok
modest
serum
igg
specif
apxiia
higher
dose
group
challeng
mice
intraperiton
inject
pleuropneumonia
kill
mice
control
nontransgen
tobacco
group
within
h
apxiia
tobacco
group
surviv
comparison
mice
immun
subcutan
recombin
e
coliexpress
apxiia
surviv
lee
et
al
although
ultim
fate
mice
beyond
h
report
appear
oral
deliveri
apxiia
tobacco
afford
protect
later
oral
immun
studi
use
apxia
apxiia
express
yeast
show
enhanc
protect
efficaci
either
toxin
deliv
alon
suggest
multipl
toxin
includ
swine
vaccin
shin
et
al
certainli
level
antigen
express
plant
must
increas
order
facilit
robust
protect
oral
deliveri
moreov
test
swine
must
perform
order
examin
potenti
protect
oral
deliveri
apx
antigen
plantbas
express
vaccin
antigen
oral
deliveri
crude
minim
process
plant
tissu
promis
antigen
express
seed
rice
corn
seed
vehicl
provid
stabl
environ
accumul
protein
thu
need
refriger
could
obviat
minim
nonetheless
antigen
express
seed
suffici
level
afford
protect
anim
upon
ingest
due
variabl
natur
protein
structur
biochem
characterist
difficult
predict
protein
accumul
well
correctli
fold
display
protect
epitop
gener
screen
optim
express
stabl
transgen
plant
line
time
laborintens
process
case
may
yield
excel
result
regulatori
agenc
substanti
concern
regard
use
plant
especi
plant
use
food
human
product
pharmaceut
protein
vaccin
issu
discuss
recent
review
rybicki
although
world
health
organ
unit
state
depart
agricultur
food
drug
administr
agre
applic
regulatori
good
manufactur
practic
requir
place
plantderiv
vaccin
enthusiasm
dim
fear
noncompli
could
compromis
food
secur
thu
invest
fund
commerci
develop
vaccin
food
crop
like
suffer
meanwhil
much
recent
work
focus
use
nonfood
plant
tobacco
rel
product
vaccin
antigen
use
robust
transient
express
via
plant
viru
replicon
gleba
et
al
huang
et
al
santi
et
al
system
provid
express
level
high
enough
facilit
purif
antigen
good
yield
concentr
enough
use
intranas
deliveri
incorpor
oral
deliveri
formul
ongo
work
develop
mucos
adjuv
synerg
effici
plant
express
system
provid
altern
vaccin
ultim
vaccin
tailor
particular
pathogen
host
agonist
pattern
recognit
receptor
eg
tolllik
receptor
show
great
promis
mucos
adjuv
deserv
research
develop
